Articles

New Medtronic CGM Approved in the EU

The Envision Pro will be factory-calibrated, disposable, and is intended for use by health care professionals.

ollaborations Announced Between Sanofi and Abbott, and Between Novo Nordisk and Medtronic

The two separate collaborations will soon allow the companies to make more readily available blood sugar readings and insulin dosing information across more diabetes devices, apps, and platforms.

Eylea, a Treatment for Diabetic Retinopathy, Now Available in Prefilled Syringes

The drug is just one of two on the market currently approved specifically to treat the diabetes-related eye condition, among other eye ailments.

Connection Found Between HbA1c and Educational Outcomes

Type 1 diabetes is an additional challenge for school-age children, but well-managed type 1 diabetes was not found to be an additional barrier to academic achievement.

ere are Six Recent Moves to Curb Co-Pay Costs for Insulin

Four insurers have introduced a cap on monthly insulin costs, but the federal government’s move to change regulations around high-deductible insurance plans may have the biggest long-term impact.

Implantable CGM Gains Blue Cross Blue Shield Coverage in Two States

Senseonics continues to make inroads in its rollout of the Eversense CGM.

GVOKE will be the first prefilled, injectable glucagon on the market.

The company also will offer a $99 monthly subscription for up to three vials or two packs of any combination of Novo Nordisk’s analog insulins.

JDRF Announces the Creation of its First Center for Excellence

The inaugural Northern California Center for Excellence will bring together key diabetes researchers investigators involved in diabetes cellular therapy and immune system research from Stanford University and UCSF.

Insulin Pumps for Beginners

Insulin Pumps for Beginners

An overview of insulin pump therapy, with Diabetes Care and Education Specialist Ashlee Ernst.